Similar observations were found in a cohort study of newly diagnosed SLE patients with anti-SSA/Ro antibodies which were present in 57% of Chinese patients compared with 28% of African American patients and 18% of Caucasians (48). The gene discussed is CALR; the disease is systemic lupus erythematosus.